U.K. Big Pharma, Big Dividends

Hikma Pharmaceuticals

Market Cap: UK£3.4b

Develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products.

GSK

Market Cap: UK£73.5b

Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.

AstraZeneca

Market Cap: UK£210.8b

A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.